Education
About Us
Working with TipRanks
Follow Us
PureTech Health (PRTC)
NASDAQ:PRTC
Earnings Data
Report Date
Apr 23, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.94Last Year’s EPS
3.6Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted PureTech's strong cash position and operational efficiency, progress in core founded entities, and strategic financing with promising valuation for Seaport Therapeutics. However, there are challenges with the need for ongoing external financing for core entities and leadership transitions. The overall sentiment is balanced with strong positive aspects but also significant challenges.Company Guidance
Strong Cash Position and Operational Efficiency
PureTech ended the half year with just under $320 million in cash, cash equivalents, and short-term investments. Operating expenses reduced from $66.7 million in the same period last year to just under $50 million, demonstrating efficient operations.
Successful Financing and Valuation of Seaport Therapeutics
Seaport Therapeutics, a core founded entity of PureTech, raised over $325 million with a $733 million post-money valuation during its Series B round.
Progress in Core Founded Entities
Significant progress in Celea Therapeutics, Gallop Oncology, and Seaport Therapeutics with promising data in IPF and cancer treatments. Notable FDA designations for LYT-200 in Gallop Oncology.
Significant Potential from Cobenfy Royalties
PureTech holds a 2% royalty on Cobenfy sales above $2 billion annually, with potential milestones projecting around $300 million in value based on analyst forecasts.
PRTC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRTC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 28, 2025 | $18.01 | $17.35 | -3.66% |
Apr 30, 2025 | $17.50 | $17.26 | -1.37% |
Aug 28, 2024 | $25.00 | $23.50 | -6.00% |
Apr 25, 2024 | $27.48 | $27.86 | +1.38% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does PureTech Health (PRTC) report earnings?
PureTech Health (PRTC) is schdueled to report earning on Apr 23, 2026, TBA (Confirmed).
What is PureTech Health (PRTC) earnings time?
PureTech Health (PRTC) earnings time is at Apr 23, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRTC EPS forecast?
PRTC EPS forecast for the fiscal quarter 2025 (Q4) is -1.94.